Mirvaso in Use Study

PHASE4CompletedINTERVENTIONAL
Enrollment

205

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Rosacea
Interventions
DRUG

Brimonidine

Trial Locations (12)

10017

Manhattan Dermatology and Cosmetic Surgery, New York

18201

DermDox Centers for Dermatology, Hazleton

33136

Florida Academic Dermatology Center, Miami

33401

Research Institute of the Southeast, West Palm Beach

48088

Grekin Skin Institute, Warren

68144

Advanced Skin Research Center, Omaha

72916

Johnson Dermatology, Fort Smith

76011

Arlington Research Center, Arlington

78218

Texas Dermatology and Laser Specialists, San Antonio

92663

Blue Harbor Dermatology, Newport Beach

95403

Redwood Dermatology Research, Santa Rosa

95819

Center for Dermatology and Laser Surgery, Sacramento

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT02249065 - Mirvaso in Use Study | Biotech Hunter | Biotech Hunter